Submandibular Sialoadenitis in an Infant Exposed to Adalimumab and Infliximab in Utero

J Crohns Colitis. 2017 Oct 1;11(10):1284-1285. doi: 10.1093/ecco-jcc/jjx045.

Authors

Thea Vestergaard¹, Birgitte Brock², Lisbet A Christensen¹, Mette Julsgaard^{1

3}

Affiliations

¹ Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
² Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
³ Department of Medicine, Horsens Hospital, Horsens, Denmark.

PMID: 28369262
DOI: 10.1093/ecco-jcc/jjx045

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / adverse effects*
Adalimumab / therapeutic use
Adult
Colitis, Ulcerative / complications
Colitis, Ulcerative / drug therapy
Female
Humans
Infant, Newborn
Infant, Newborn, Diseases / etiology*
Infliximab / adverse effects*
Infliximab / therapeutic use
Pregnancy
Pregnancy Complications / drug therapy
Sialadenitis / etiology*
Submandibular Gland Diseases / etiology*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Tumor Necrosis Factor-alpha
Infliximab
Adalimumab